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High-dimensional single-index Bayesian
modeling of brain atrophy
Arkaprava Roy∗,§ , Subhashis Ghosal†,§ Kingshuk Roy Choudhury‡ and For The
Alzheimer’s Disease Neuroimaging Initiative¶
Abstract. We propose a model of brain atrophy as a function of high-dimensional
genetic information and low dimensional covariates such as gender, age, APOE
gene, and disease status. A nonparametric single-index Bayesian model of high
dimension is proposed to model the relationship with B-spline series prior on the
unknown functions and Dirichlet process scale mixture of centered normal prior
on the distributions of the random effects. The posterior rate of contraction with-
out the random effect is established for a fixed number of regions and time points
with increasing sample size. We implement an efficient computation algorithm
through a Hamiltonian Monte Carlo (HMC) algorithm. The performance of the
proposed Bayesian method is compared with the corresponding least square esti-
mator in the linear model with horseshoe prior, LASSO and SCAD penalization
on the high-dimensional covariates. The proposed Bayesian method is applied to
a dataset on volumes of brain regions recorded over multiple visits of 748 indi-
viduals using 620,901 SNPs and 6 other covariates for each individual, to identify
factors associated with brain atrophy.
Keywords: ADNI, Bayesian, GWAS, Hamiltonian Monte Carlo, high-dimensional
data, single-index Model, Spike and Slab prior.
1 Introduction
Alzheimer’s disease (AD) is a progressive neurodegenerative disease that affects approx-
imately 5.5 million people in the United States and about 30 million people worldwide.
It is believed to have a prolonged preclinical phase initially characterized by the develop-
ment of silent pathologic changes when patients appear to be clinically normal, followed
by mild cognitive impairment (MCI) and then dementia (AD) (Petrella (2013)). Apart
from its manifestation in the impairment of cognitive abilities, disease progression also
produces a number of structural changes in the human brain, which includes the depo-
sition of amyloid protein and the shrinkage or atrophy for certain regions of the brain
over time (Thompson et al. (2003)). Previous studies have shown that the rate of brain
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2 Bayesian single-index model for the Brain Atrophy
atrophy is significantly modulated by a number of factors, such as gender, age, baseline
cognitive status and most markedly, allelic variants in the Apolipoprotein E (APOE)
gene (Hostage et al. (2014)). In this paper, we examine if any other genes are also im-
plicated in modulating the rate of brain atrophy along with examining effects of the low
dimensional covariate on the rate of atrophy using the data, collected by Alzheimer’s
Disease Neuroimaging Initiative (ADNI).
We model regional brain volume, which has been measured from magnetic resonance
(MR) images using a segmentation procedure and recorded in the ADNI database. We
collect this data directly from ADNI. We have volumetric measurements over six visits of
thirteen disjoint brain regions and a total brain measure which is a summary measure of
total brain parenchyma, including the Cerebral-Cortex, Cerebellum-Cortex, Thalamus-
Proper, CaudatePutamen, Pallidum, Hippocampus, Amygdala, Accumbens-area, Ven-
tralDC, Cerebral-White-Matter, Cerebellum-White-Matter, and WM-hypointensities.
These visits are roughly around six months apart. Thus the subjects are scanned roughly
for three years. The anatomic structures of the brain also differ across different indi-
viduals and are assumed to be dependent on subject-specific covariates like genetic
variations, gender, age etc. In this paper, we propose a model to study the effects of
these different covariates along with Alzheimer’s disease state on brain atrophy in dif-
ferent brain regions. This analysis represents a technical challenge because the genomic
data is high-dimensional and needs to be incorporated in a model for longitudinal pro-
gression of brain volumes measured in multiple parts of the brain in a non-parametric
setup. A schematic of the regions, we studied here, are depicted in the Figure 1. This
image is obtained from Ahveninen et al. (2012). Although our analysis does not have
any association with this paper, an image from it is used to show the brain regions used
for the analysis in our paper. We have not collected the data directly from the magnetic
resonance (MR) images according to some brain parcellation atlas. We got the data in
a preprocessed form from ADNI itself. (Hostage et al., 2014) had also used a similar set
of regions of interest.
We consider two separate sets of unknown functions of covariates X and Z to
model the volumetric measurements of the first visit and rates of changes for differ-
ent regions. These functions have two inputs. The first X consists of high-dimensional
single-nucleotide polymorphism (SNP) of each individual, and the other Z consists of
low-dimensional covariates like gender, age, disease state, APOE gene status of each
individual. The effect of these covariates on brain volume is modelled using a semi-
parametric function of the form {a0,j(X ′β, Z ′η) : j = 1, . . . , 14} for the volumetric mea-
surements of the first visit and {a1,j(X ′β, Z ′η) : j = 1, . . . , 14} for the rate of change
in the jth region and the coefficients β and η are unit vectors of appropriate dimen-
sions. A finite random series prior is put on the functions based on tensor products
of B-splines with appropriate prior distribution on the coefficients. To take care of the
high-dimensionality of X, the coefficient β is assumed to be sparse. We reparametrize
β in polar coordinates to incorporate sparsity in its prior. We incorporate the effect
of time in the modeling by an increasing function which is estimated nonparametri-
cally also using a finite random series of B-splines with an appropriate prior on the
coefficients.
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Figure 1: Anatomic parcellation of cortical surface from different angles showing brain
regions used for analysis. (courtesy: Ahveninen et al. (2012))
Apart from proposing a sophisticated model for studying brain atrophy, the proposed
method develops a new estimation scheme for a general high-dimensional single-index
model. Estimation for high-dimensional single-index model was previously addressed
in Zhu and Zhu (2009), Yu and Ruppert (2002), Wang et al. (2012), Peng and Huang
(2011), Radchenko (2015) and Luo and Ghosal (2016). All of them used the `1-penalty
and used optimization techniques to get the estimates. In a Bayesian framework, An-
toniadis et al. (2004) used the Fisher–von Mises prior for the directional vector. This
cannot be easily modified for a high-dimensional covariate as then we shall need a prior
which favors many zeros in the unit vector. Another paper addressing sparse Bayesian
single-index model estimation is Alquier and Biau (2013). Even though their method is
theoretically attractive, it is difficult to implement for high-dimensional covariate due
to its high computational complexity. Wang (2009) developed a Bayesian method for
sparse single-index model using the reversible jump Markov chain Monte Carlo (MCMC)
technique which is computationally expensive, especially in the high-dimensional set-
ting. We introduce a new way of incorporating sparsity on a unit vector by a spike and
slab prior via the polar form. The computation scheme is based on an efficient gradient
based Hamiltonian Monte Carlo (HMC) algorithm.
The rest of the paper is organized as follows. Section 2 discusses the dataset and
modeling in more detail. In Section 3, we describe the prior on different parameters of
the model. Section 4 describes posterior computation in this setup. We study the pos-
terior rate of contraction in the model in Section 5 under the asymptotic regime that
the number of individuals goes to infinity but the number of time points where mea-
surements are taken and the number of regions is fixed. We present a simulation study
comparing the proposed Bayesian procedure with its linear counterpart in Section 6.
The concentration of the posterior justifies the use of the proposed Bayesian procedure
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from a frequentist perspective. In Section 7, we present conclusions from the ADNI data
on brain atrophy described above using our proposed method. Section 8, concludes the
paper with some further remarks.
2 Data description and modeling
Data used in the preparation of this article were obtained from the Alzheimer’s Disease
Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). ADNI was launched
in 2003 as a public-private partnership, led by Principal Investigator Michael W. Weiner,
MD. The primary goal of ADNI has been to test whether serial magnetic resonance
imaging (MRI), positron emission tomography (PET), other biological markers, and
clinical and neuropsychological assessment can be combined to predict the progression
of mild cognitive impairment (MCI) and early Alzheimer’s disease (AD). In the ADNI
dataset, the grey matter part of the brain is divided into thirteen disjoint regions. The
volume of these regions and the summary measure of the whole brain are recorded over
time for n = 748 individuals. The visits are scheduled after each 6 months over a span of
36 months. Not all of the participants turned up at each of those scheduled visits. There
was no record of visiting after 30-th month for any of the participants. The volume data
of J = 14 regions which include thirteen brain regions and the summary measure of
the whole brain over Ti set of time points for the ith individual, for i = 1, . . . , 748 is
collected where 1 ≤ |Ti| ≤ 6. The notation |Ti| denotes cardinality of the set Ti. For
some of the participants, the disease status changed during the span of this study. They
were very small in number. We do not include them in this study.
In ADNI, the subjects were genotyped using the Human 610-Quad BeadChip (Il-
lumina, Inc., San Diego, CA), yielding a set of 620,901 SNP and copy number vari-
ation (CNV) markers. The APOE gene has been the most significant gene in GWAS
of Alzheimer’s disease. The corresponding SNPs, rs429358 and rs7412, are not on the
Human 610-Quad Bead-Chip. At the time of participant enrollment, APOE genotyping
was performed and included in the ADNI database. The two SNPs (rs429358, rs7412)
define the epsilon 2, 3, and 4 alleles and therefore were not genotyped using DNA ex-
tracted by Cogenics from a 3 mL aliquot of EDTA blood. These alleles are considered
separately in the study.
Thus apart from the volumetric measurements, we also have high-dimensional SNP
data and data on some other covariates for each individual. The other covariates are gen-
der, disease state, age and allele 2 and 4 of the APOE gene. Except for the covariate age,
all other low-dimensional covariates are categorical. To represent the categories, we use
binary dummy variables. Since the disease status has three states— NC (no cognitive im-
pairment), MCI (mild cognitive impairment) and AD (Alzheimer’s disease), we consider
two dummy variables ZAD and ZMCI respectively standing for the onset of MCI and AD,
setting NC at the baseline. Similarly, the dummy variable ZM indicating male gender is
introduced setting females at the baseline. Also, we introduce ZAPOE,2, ZAPOE,4 stand-
ing for Alleles 2 and 4 for the two alleles APOEallele2 and APOEallele4 together setting
Allele 3 as a baseline for each of the two cases. We consider the age corresponding to
the initial visit as a covariate as well. Let Z = (ZMCI, ZAD, ZM,Age, ZAPOE,2, ZAPOE,4)
stand for the whole vector of covariates. The continuous variable, Age, is standardized.
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With time, different brain regions change differently. We study the effects of different
attributes to these changes. For every individual, the volume of a brain region on a
particular visit should primarily depend on the volume of that region at the zeroth
visit and the rate of change of volume for that region with time. These rates of changes
are region-specific as well as individuals-specific. Hence, it is logical to consider the
baseline volume and the rate of change as functions on the subject and brain region. As
the geometry of brain structure is complicated, we do not assume a form of standard
spatial dependence between measurements across brain regions. Thus we need two sets
{a0,j(·, ·), a1,j(·, ·) : j = 1, . . . , 14} of functions for modeling volume at the initial visit
and the rate of change for the jth region. These functions are unknown and are modeled
nonparametrically. For nonparametric regression problems, single-index models provide
a lot of flexibility in estimation and interpretation of the results. Hence we adopt the
bivariate single-index model with two inputs for high-dimensional and low-dimensional
covariates separately for easy interpretation and computational efficiency. The effect of
time is captured through an unknown increasing function F0(·), which is bounded in
[0, 1]. This is also modeled nonparametrically.
Let Yijt be the volume of the jth brain region for the ith individual at the tth time
point in the logarithmic scale, Xi is high-dimensional SNP expression of length p for
the ith individual, t ∈ Ti/36, i = 1, . . . ,m and j = 1, . . . , 14. The visit times are divided
by 36 to keep it bounded in [0, 1]. Then the data generating process can be represented
through the following specification
Yijt = Fijt + εijt, εijt ∼iid N(0, σ2), (2.1)
Fijt = a0,j(X
′
iβ, Z
′
iη)− a1,j(X ′iβ, Z ′iη)F0(t),
where a0,j(·, ·), a1,j(·, ·), F0(·) are all unknown continuous functions and N stands for a
normal distribution. The function F0(·) is monotone increasing functions from [0, 1] to
[0, 1] and F0(0) = 0, F0(1) = 1. The other two functions a0,j(·, ·), a1,j(·, ·) maps from
[−1, 1]2 to (−∞,∞). For identifiability of the functions along with the parameters β
and η, we assume that ‖β‖ = 1, ‖η‖ = 1; here ‖ ·‖ denotes L2-norm of a vector. We also
normalize the covariates for each individual i.e. Xi and Zi for each i such that ‖Xi‖ and
‖Zi‖ are one. This is to ensure that X ′iβ and Z ′iη are bounded between [−1, 1] for each
i. For nonparametric function estimation, bounded domain is important for uniform
approximation using the basis expansion. The biggest challenge for estimation in this
model is the high-dimensionality of β. To identify important SNPs from X, we need to
perform variable selection. To do that, we propose a sparse estimation scheme for β.
First we reparametrize the two unit vector β = (β1, . . . , βp) and η = (η1, . . . , ηk) to their
respective polar forms which allow us to work with Euclidean spaces. In this setup, only
the directions of β and η are identifiable. Note that β and −β have the same directions.
In the polar setup, for s = 1, . . . , p − 1, βs =
∏s−1
l=1 sin θl cos θs, and βp =
∏p−1
l=1 sin θl
where {θ = (θ1, . . . , θp−1)} is the polar angle corresponding to the unit vector β. Here
θs ∈ [0, pi] for s = 1, . . . , (p − 2) and θp−1 ∈ [0, 2pi]. Similarly, let α be the polar angle
corresponding to η. Then for s ≤ k − 1, ηs =
∏s−1
l=1 sinαl cosαs and ηk =
∏k−1
l=1 sinαl.
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3 Prior specification
In the nonparametric Bayesian setup described above, we induce prior distributions on
the smooth functions a0,j and a1,j in (2.1) through basis expansions in tensor products
of B-splines and suitable prior for the corresponding coefficients. Given other parameters
in this setup, a normal prior distribution on the coefficients of the tensor products of
B-splines will lead to conjugacy and faster sampling via Gibbs sampling scheme. An
inverse gamma prior on σ2 is an obvious choice due to conjugacy and faster sampling.
We also put a B-spline series prior on the smooth increasing function of time F0(·).
The coefficients for this function would be increasing in the index of the basis functions
and lie in (0,1]. To put a prior on an increasing sequence, we introduce a set of latent
variables of size equal to one less than the number of B-spline coefficients. Then the B-
spline coefficients would be normalized cumulative sum of those latent variables. Other
two parameters β and η are reparametrized into their polar coordinate system. The
parameter space of the polar angles will be a hyper-rectangle. It will be easier to put
prior on the polar angles. To estimate using the sparsity of β, we need to carefully
put a shrinkage prior to the polar angles. A polar angle of pi/2 will ensure that the
corresponding coordinate in the unit vector equals to zero. When there is sparsity in
the unit vector, most of the polar angles will be pi/2. Thus a spike and slab prior to
polar angle with a spike at pi/2 should be able to capture sparsity in the corresponding
unit vector. The last polar angle has spike both at the multiples of pi and pi/2, due to
the special structure of the last and the penultimate co-ordinates of a unit vector in
the polar form. If it a multiple of pi, then the last coordinate is zero and if it is an odd
multiple of pi/2, then the penultimate coordinate is zero. The support of the last polar
angle is [0, 2pi] and we need spikes at all multiples of pi and pi/2. The prior is constructed
to maintain that structure of spikes. Since only the directions of β and η are identifiable,
the intercept and slope functions are modeled as even functions i.e. symmetric around
zero.
Now we describe the prior in details. Let dxe denote the lowest integer greater than
or equal to x.
(i) Intercept and slope functions: Let aν,j(x, y) =
∑K
m=1
∑K
m′=1 λν,j,mm′Bm(x)B
′
m(y),
ν = 0, 1, with λν,j,mm′ = λν,j,(K−m)m′ , λν,j,mm′ = λν,j,m(K−m′) for ν = 0, 1,
and λν,j,mm′ ∼ N(0, a2), 1 ≤ m,m′ ≤ dK/2e, for some chosen a > 0. Further,
K is given a prior with probability mass function of the form Π(K = k) =
b1 exp[−b2k2(log k)b3 ], with b1, b3 > 0 and 0 ≤ b3 ≤ 1.
(ii) The function of time: Let F0(x) =
∑K′
l=1 λlBl(x), with 0 = λ1 ≤ λ2 ≤ · · · ≤
λK′ = 1. We put a prior on (λ2, . . . , λK′−1) by reparameterizing as λl+1 =
(
∑l
i=1 δi)/(
∑K′−1
i=1 δi), and putting the prior δi ∼ Un(0, 1) for l = 1, . . . ,K ′ − 1,
where Un stands for the uniform distribution. Further, K ′ is given a prior with
probability mass function of the form Π(K ′ = k) = b′1 exp[−b′2k(log k)b
′
3 ] with
b′1, b
′
2 > 0 and 0 ≤ b′3 ≤ 1.
(iii) Error variance: We put σ−2 ∼ Ga(d1, d2), where Ga stands for the gamma distri-
bution.
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(iv) Polar angles α of η: We let αr ∼ Un(0, pi), r = 1, . . . , (k−2), and αk−1 ∼ Un(0, 2pi),
independently.
(v) Polar angles θ of β: We put a spike and slab prior on the polar angles that has
spike at pi/2 for the first polar angle and all the multiples of pi/2 for the last polar
angle. Then the spike distribution would look like Figure 2. The spike and slab
prior for θr, r ≤ (p− 2), has density given by
(1− γi) Γ(M1 +M2)
Γ(M1)Γ(M2)
(
min(θr, pi − θr)
pi/2
)M2(
1− min(θr, pi − θr)
pi/2
)M1
+ γi
1
pi
,
for 0 < θr < pi and the distribution of θp−1 is given by
θp−1 ∼ (1− γi)1
8
[Be(M1,M2)[0,pi/4] + Be(M2,M1)[pi/4,pi/2]
+Be(M1,M2)[pi/2,3pi/4] + Be(M2,M1)[3pi/4,pi] + Be(M1,M2)[pi,5pi/4]
+Be(M2,M1)[5pi/4,3pi/2] + Be(M1,M2)[3pi/2,7pi/4] + Be(M2,M1)[7pi/4,2pi]]
+γiUn(0, 2pi);
here Be(M1,M2)[a,b] denotes the beta distribution with shape parameters M1 and
M2, supported within the interval [a, b], and M1 < 1 ≤M2. The indicator variable
γ ∼ Ber(q).
The spike distribution on θ looks like Figure 2. The first plot is for the first (p− 2)
angles and the second plot is for the last polar angle.
Note that either geometric or Poisson distribution (respectively b′3 = 0 and 1) can
be chosen as prior on K ′, the number of terms to be used in the B-spline series for
the growth function F0. For K, the square, which is the number of terms in the tensor
product series representation, can have a geometric or Poisson-like tail.
Model selection: Polar angles with a posterior probability of selection in the model
more than 0.5 are considered in the model.
4 Computation
Now the conditional log-likelihood is given by
C −
∑
ijt
1
2σ2
(
Yijt −
K∑
m=1
K∑
m′=1
λ0,j,mm′Bm(
p−1∑
s=1
Xis
s−1∏
l=1
sin θl cos θs +Xip
p−1∏
l=1
sin θl)
×B′m(
k−1∑
s=1
Zis
s−1∏
l=1
sinαl cosαs + Zik
k−1∏
l=1
sinαl)
+
K∑
m=1
K∑
m′=1
λ1,j,mm′Bm(
p−1∑
s=1
Xis
s−1∏
l=1
sin θl cos θs +Xip
p−1∏
l=1
sin θl)
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Figure 2: Spike distribution with M1 = 0.01 and M2 = 10.
×B′m(
k−1∑
s=1
Zis
s−1∏
l=1
sinαl cosαs + Zik
k−1∏
l=1
sinαl)
K−1∑
m=1
∑m
i=1 δi∑K′−1
i=1 δi
Bm+1(t)
)2
−
∑
m,m′,j
λ20,j,mm′ + λ
2
1,j,mm′
2a2
+
p−1∑
l=1
log
(
(1− γl)θ′M1−1l (1− θ′l)M2−1
Γ(M1 +M2)
Γ(M1)Γ(M2)
+ γl
)
− (J
∑
i
Ti/2 + d1 − 1) log σ2 − d2/σ2,
where C involves only the hyperparameters a,M2,M1,K, d1, d2 and the observations
but not parameter of the model.
All B-spline coefficients and σ are updated using the conjugacy structure. Using
derivative of B-splines (De Boor, 2001), it is possible to calculate the derivatives of the
log-likelihood with respect to the polar angles and δ’s of F0(t). Thus, we implement
efficient gradient based MCMC algorithm using Hamiltonian Monte Carlo algorithm,
described in (Neal, 2011). Since these parameters have bounded support, the candidates
for a Metropolis step are reflected back if they cross the boundaries. For example if a
candidate θci of θi is more than pi, then it is re-adjusted as θ
c
i = pi − (θci − pi). Similar
adjustment is done if θci becomes smaller than zero as well. Similar strategies are adopted
while updating δ’s as well. All the posterior updates are discussed in the supplementary
materials.
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In our computation of the model, we are not using the priors on K and K ′ i.e. the
number of B-spline basis functions as it will require reversible jump MCMC strategy
which is computationally expensive. Thus, these are chosen by minimizing the Bayesian
Information Criterion (BIC) after fitting the model over a grid of a number of B-spline
basis functions for randomly generated 10 different choices of β and η. We generate 10
different choices for β and η and then fit the non-linear model for different choices of
a number of B-spline basis functions within the range [7, 20]. After taking an average
overall 10 BIC values for each case, we take the number as optimal that has the least
BIC value. Convergence of the MCMC chain is diagnosed using trace plots.
5 Large-sample Properties
In this section, we examine large sample properties of the proposed Bayesian procedure
for the model (2.1). We have observations for fixed J number of regions and T many time
points. We show posterior consistency in the asymptotic regime of increasing sample
size and increasing dimension p of SNPs.
We study posterior contraction rate with respect to the empirical `2-distance on the
regression function, which is defined as follows. For two sets of parameters (F, a, β, η)
and (F ∗, a∗, β∗, η∗), the empirical `2-distance is given by
d2((F, a, β, η), (F ∗, a∗, β∗, η∗))
=
1
J
∑n
i=1 Ti
J∑
j=1
n∑
i=1
Ti∑
t=1
|a0,j(X ′iβ, Z ′iη) + a1,j(X ′iβ, Z ′iη)F (t)
−a∗0,j(X ′iβ∗, Zi”η∗)− a∗1,j(X ′iβ∗, Z ′iη∗)F ∗(t)|2,
and a = (a0,j , a1,j : j = 1, . . . , J), a
∗ = (a∗0,j , a
∗
1,j : j = 1, . . . , J).
Since β is a high-dimensional parameter, sensible estimation is possible only if it has
sparsity, which must be picked up by the prior. In the setting of a spike-and-slab prior
for polar coordinates described in Section 3, we need to ensure sufficient concentration
near pi/2 by choosing a large value of the second parameter M2 in the beta spike
distribution (depending on the sample size n and the dimension p) and a small value of
the probability of slab γ. More precisely, we choose M1 ≤ 1 fixed, M2 > √np log p and
γ = o(p−1). Then the contraction rate will be determined by the smoothnesses of the
underlying true functions a0,0, a0,1 and F0,0, the sparsity s0 of true high-dimensional
regression coefficient β0 and mildly on the parameter b3, b
′
3 in the prior distribution for
the number of basis elements K,K ′ used in the B-spline bases, as shown by the following
result.
Theorem 1. Assume that the true function F0,0 belongs to the Ho¨lder class of regu-
larity level ι′ on [0, 1] and the true coefficient functions (a0,0,j , a1,0,j :, j = 1, . . . , J) are
Ho¨lder smooth function of regularity level ι on [−1, 1]× [−1, 1]. Let the true regression
coefficient β0 for the high-dimensional covariate X have s0 non-zero co-ordinates. Then
the posterior contraction rate with respect to the distance d is
max
{
n−ι/(2ι+2)(log n)ι/(2ι+2)+(1−b3)/2, n−ι
′/(2ι′+1)(log n)ι
′/(2ι′+1)+1−b′3 ,
√
s0 log p
n
}
.
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In the above result, since the observation points are not dense over the domain,
posterior contraction on the function is based on its distance with the true function
only at the observation points.
The proof of the theorem uses the general theory of posterior contraction (see Ghosal
and van der Vaart (2017)) for independent non-identically distributed observations and
some estimates for finite random series based on B-splines. The proof is given in the
supplementary materials part.
6 Simulation
We compare our method with some common penalization methods based on the follow-
ing simplified linear model
log Yijt = X
′
iβ + Z
′
iη + γ1,j − (X ′iβ + Z ′iη + γ2,j)t+ εijt, (6.1)
t = 1, . . . , Ti, i = 1, . . . , n, j = 1, . . . , 13. In the above model, β is a sparse vector and
all other parameters are unpenalized. The performance of these methods is compared
based on MSE values on a test set under the scenarios the linear model is correct and
the linear model is false.
We generate a high dimensional binary matrix X and a low-dimensional covariate
matrix Z. The true data matrices of the real data are in the support of the scheme of
sampling the high dimensional matrix as well as the low dimensional matrix.
Data generation for the non-linear case:
• Generate a data matrix X with elements coming from Bernoulli distribution with
success probability of the ith row as pi.
• Generate pi, i = 1, . . . , n, from the standard uniform distribution.
• Generate all the elements of the matrix Z from N(0, 1).
• Generate the sparse vector β0 with 5% elements non-zero. Positions for non-zero
elements are chosen first at random by sampling p/20 elements from total p po-
sitions, where p is the length of β0. The non zero elements are generated from
mixture distribution of two normals N(2, 1) and N(−1, 1).
• Set the value of η0 to (1,−2, 4.3, 10,−8).
• Normalize each row of X and Z along with β0 are η0 to the unit norm.
We let the true functions be
a0,0,j(x, y) = 2((j/13)x)
3 + 2((1− j/13)y)3,
a0,1,j(x, y) = 2 exp((j/13)y) + 2 exp((1− j/13)x),
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j = 1, . . . , 13, and F0,0(t) = t
2. After generating the true functional values, the data
Yijt is generated from N(a0,j(X
′
iβ0, Z
′
iη0)− a1,j(X ′iβ0, Z ′iη0)F0(t), 1).
Data generation for the linear case:
In this case, the true model is the one given in (6.1). All the steps for generating
X, Z, β0 and η0 are as given above. The coefficients γ1,j and γ2,j , j = 1, . . . , 13, are
generated from N(0, 1). After generating the design matrix, the data Yijt is generated
from N(Xiβ0 + Ziη0 + γ1,j − (Xiβ0 + Ziη0 + γ2,j)t, 1)
For the data generation, we set the error standard deviation σ0 = 1. We compare the
prediction MSEs across all the methods. We split the whole data into two equal parts
for training and testing. We compare the performance of our method with LASSO
(Tibshirani (1996)), SCAD (Fan and Li (2001)) and horseshoe (Carvalho et al., 2010)
on testing dataset based estimates of parameters from the training dataset. We use the
R package glmnet for LASSO and ncvreg for SCAD. We developed and used an HMC
sampler for the horseshoe prior. For sample sizes 200, 500 and 1000, we gather the
mean squared error (MSE) values both for non-linear and linear cases. We use half of
the sample for training and the remaining half for testing. Among other parameters, we
consider thirteen regions in total, five time points and vary the value of p as 5000, 10000
and 20000. We include one case for ultra high dimension of p = 100000 and sample size
200. We set M1 = 0.1,M2 = 10 and tune q to ensure a good acceptance rate and desired
model size (sum of γi’s) across MCMC samples. We consider to maintain the desired
model size between 20 and 30 at each step of the MCMC iterations. The results are
summarized below for 50 replications and 3000 post burn samples after burn-in 1000
samples. The number of basis functions for spline is different across different sample
sizes. To fit our model we vary the number of B-spline basis function as 8 for n = 200,
11 for n = 500, and 14 for n = 1000. These numbers are chosen according to the strategy
described in the Section 4. Let I0 be the set of indices such that {i : β0i 6= 0}. We have
in total 26 non-zero variables. From the posterior samples of γ, we can identify the
top 26 selected variables. For other methods, we select the variables with the highest
26 magnitudes in βˆ and ignore the ones with very low magnitudes relative to others.
Let Xˆ denotes the final selected set of variables for different cases and let XI0 be the
true set of variables. To examine variable selection, we report the maximum canonical
correlation between Xˆ and XI0 for each case in the bracket.
From Table 1, we infer that the performance of the proposed Bayesian method based
on the high-dimensional single-index model is always much better than the LASSO, the
SCAD and horseshoe for the non-linear case. For the linear case in Table 2, it is com-
petitive with linearity based methods like the LASSO, the SCAD and horseshoe. This
is natural as the LASSO, the SCAD or the horseshoe use more precise modeling in-
formation which the semiparametric methods cannot use. But, in terms of maximum
canonical correlations, our model outperforms in the non-linear case and remains ex-
tremely competitive for the linear case.
imsart-ba ver. 2014/10/16 file: main.tex date: February 12, 2019
12 Bayesian single-index model for the Brain Atrophy
Table 1: Comparison of the proposed high-dimensional single-index model with LASSO,
SCAD and horseshoe in terms of MSE and maximum canonical correlation between
selected set of variables and true set of variables in the bracket for non-linear case.
Total Dimension SIM LASSO SCAD Horseshoe
sample size of β (p) MSE MSE MSE MSE
200 5000 3.33 (0.84) 6.93 (0.37) 7.32 (0.71) 6.24(0.60)
500 5000 3.43(0.75) 6.11 (0.32) 6.03 (0.69) 7.46(0.61)
1000 5000 3.27(0.76) 6.36 (0.18) 7.08 (0.69) 6.89(0.60)
200 10000 3.42(0.84) 6.32 (0.12) 7.16 (0.69) 8.33(0.59)
500 10000 3.09(0.74) 6.69 (0.34) 7.80 (0.66) 7.18(0.58)
1000 10000 3.25 (0.77) 6.01 (0.35) 7.13(0.67) 7.84(0.58)
200 20000 3.40 (0.83) 6.88 (0.07) 7.75 (0.70) 5.24(0.61)
500 20000 3.31 (0.74) 6.54 (0.34) 7.20 (0.67) 7.54(0.60)
1000 20000 3.15 (0.75) 6.12 (0.25) 7.03 (0.70) 7.86(0.55)
Table 2: Comparison of the proposed high-dimensional single-index model with LASSO,
SCAD and horseshoe in terms of MSE and maximum canonical correlation between
selected set of variables and true set of variables in the bracket for linear case.
Total Dimension SIM LASSO SCAD Horseshoe
sample size of β (p) MSE MSE MSE MSE
200 5000 1.67 (0.92) 1.02 (0.59) 1.01 (0.86) 1.01 (0.72)
500 5000 1.48 (0.71) 1.01 (0.43) 1.02 (0.74) 1.01 (0.66)
1000 5000 1.61 (0.71) 1.00 (0.49) 1.02 (0.70) 1.00 (0.66)
200 10000 1.61 (0.78) 1.02 (0.39) 1.01 (0.76) 1.00 (0.78)
500 10000 1.48 (0.65) 1.01 (0.38) 1.02 (0.66) 1.02 (0.58)
1000 10000 1.65 (0.66) 1.01 (0.40) 1.02 (0.64) 1.01 (0.59)
200 20000 1.35 (0.79) 1.03 (0.22) 1.01 (0.73) 1.01 (0.65)
500 20000 1.24 (0.72) 1.02 (0.35) 1.01 (0.73) 1.00 (0.66)
1000 20000 1.31 (0.70) 1.01(0.45) 1.02(0.65) 1.01 (0.60)
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7 Real-data analysis
7.1 Modification of the model for real data application
Incorporating random effect and region wise varying effect
As the data are longitudinal, it is reasonable to add subject specific random effect (τi)
in the model and vary the effect of the low dimensional covariates region-wise. The new
modified model will then become
Yijt = Fijt + τi + εijt, εijt ∼ N(0, σ2),
Fijt = a0,j(X
′
iβ, Z
′
iηj)− a1,j(X ′iβ, Z ′iηj)F0(t), (7.1)
t = 1, . . . , Ti with 1 ≤ Ti ≤ 6, j = 1, . . . , 14, i = 1, . . . , 748.
Prior on the random effects
We put a Dirichlet process scale mixture of normal prior on the random effect dis-
tribution.
Region-wise varying effect with no SNP
To compare the nonlinear model with the linear model of Hostage et al. (2014), we also
fit the following model without the SNPs,
Yijt = Fijt + τi + εijt, εijt ∼ N(0, σ2),
Fijt = a0,j(Z
′
iηj)− a1,j(Z ′iηj)F0(t), (7.2)
t = 1, . . . , Ti with 1 ≤ Ti ≤ 6, j = 1, . . . , 14, i = 1, . . . , 748.
Corresponding Linear Model
We compare the performance of our above non-linear models with following linear model,
Yijt = Hijt + τi + εijt, εijt ∼ N(0, σ2),
where t = 1, . . . , Ti with 1 ≤ Ti ≤ 6, j = 1, . . . , 14, i = 1, . . . , 748, and
Hijt =%j0 + %
0
j,MZi,M + %
0
j,ADZi,AD + %
0
j,NCZi,NC + %
0
j,Allele4Zi,Allele4
+ %0j,Allele2Zi,Allele2 + %
0
j,AgeZi,Age + %
0
j,AD,Allele2Zi,ADZi,Allele2
+ %0j,AD,Allele4Zi,ADZi,Allele4 + %
0
j,NC,Allele2Zi,NCZi,Allele2
+ %0j,NC,Allele4Zi,NCZi,Allele4 −
[
%j1 + %
1
j,MZi,M + %
1
j,ADZi,AD + %
1
j,NCZi,NC
+ %1j,Allele4Zi,Allele4 + %
1
j,Allele2Zi,Allele2 + %
1
j,AgeZi,Age
+ %1j,AD,Allele2Zi,ADZi,Allele2 + %
1
j,AD,Allele4Zi,ADZi,Allele4
+ %1j,NC,Allele2Zi,NCZi,Allele2 + %
1
j,NC,Allele4Zi,NCZi,Allele4
]
t. (7.3)
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We have the volumetric measurement data for the total thirteen brain regions along
with the summary measure of the whole brain over time for 748 individuals. For each
individual, the covariate information is summarized in Table 3. The baseline subject for
our analysis is a female individual with average age and no cognitive impairment.
Table 3: Demographic table to summarize data in terms of number of no cognitive
impaired (NC), Alzheimer’s disease (AD) and mildly cognitive impaired (MCI) partic-
ipants along with the age across the two gender groups male and female.
Female Male
Number of NC participants 99 114
Number of AD participants 84 94
Number of MCI participants 122 235
Number of participants with APOEgene allele2 29 29
Number of participants with APOEgene allele4 150 223
Average age 73.51 74.60
Standard deviation of Age 6.67 6.80
We first fit the model in (7.2) and the following linear model in (7.3) in accordance
with Hostage et al. (2014) with same set of covariates and interactions between APOE
and disease states. Then we compare the prediction MSE. Prediction error gives us
the predictive performance and fitted relative MSE helps to judge the reliability of
inference. We consider 17 basis B-spline functions for univariate and 172 basis functions
for bivariate cases. The estimates are based on 5000 post-burn MCMC samples after
burning-in the first 1000 samples.
To compare the fitted models, we calculate the prediction error in each model. To
calculate the prediction error, we divide the whole dataset into training (Tr) and testing
(Te) sets. We use the stratified sampling using each subject-region pair as stratum so
that training will have all the individuals that belong to the testing set. This is important
for prediction with a random effect in the model. The formula for prediction error will
be |Te|−1∑(i,j,t)∈Te(Yijt− Yˆijt)2; here |Te| denotes total number of elements in the test
set Te. The linear model gives the prediction error 3.83 whereas that in our non-linear
model hugely improves to 0.07. The model in (7.1) with SNPs betters the prediction
error to 0.06 which is around 14% improvement.
After selecting the significant genes, we calculate the Bayesian information criterion
(BIC) of models leaving out one of the low-dimensional covariates every time with all
the genes to compare the significance. If BIC for the model leaving out covariate A is
higher than the model leaving out covariate B, then covariate A is more significant than
covariate B. The table below gives an ordered list of the significance of low-dimensional
covariates for different regions in Tables 4. In Table 5, we show the estimates from the
linear model in (7.3) for the whole brain.
We map the significant SNPs from our analysis to the corresponding genes using the
R package rsnps. We tune the parameter γ in the model to select the 20 most significant
SNPs. Among those, we could map 11 of those to some genes. The significant genes from
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Table 4: Low dimensional covariates of the model in 7.2 with selected genes for different
brain regions in their order of significance, 1 being the most significant.
1 2 3 4 5 6
Total Brain Age APOE-allele4 APOE-allele2 Gender MCI AD
Ventricles MCI APOE-allele4 Gender AD APOE-allele2 Age
Left-
Hippocampus APOE-allele4 Gender MCI APOE-allele2 AD Age
Right-
Hippocampus MCI APOE-allele4 APOE-allele2 Gender AD Age
LINFLATVEN APOE-allele4 Gender AD MCI APOE-allele2 Age
RINFLATVEN APOE-allele4 AD MCI Gender APOE-allele2 Age
Left Medial-
Temporal MCI Age APOE-allele4 APOE-allele2 Gender AD
Right Medial-
Temporal Gender APOE-allele4 APOE-allele2 Age MCI AD
Left Inferior-
Temporal APOE-allele4 APOE-allele2 MCI Age Gender AD
Right Inferior -
Temporal APOE-allele4 MCI APOE-allele2 AD Age Gender
Left Fusiform Gender MCI Age APOE-allele4 APOE-allele2 AD
Right Fusiform APOE-allele4 Age MCI APOE-allele2 Gender AD
Left Entorhin APOE-allele4 Gender MCI Age AD APOE-
allele2
Right Entorhin APOE-allele4 Gender Age MCI AD APOE-
allele2
our analysis are mentioned in Section 8 along with some previous studies that found
the corresponding gene significant for the AD and/or cerebral atrophy.
8 Conclusions and discussion
We fit a bivariate single-index model to capture the volumetric change of different cor-
tical regions in the human brain. There are both high and low-dimensional covariates as
input to the unknown functions determining initial configuration and rate of change of
different regions. To tackle the high-dimensional covariate within a single-index model,
we provide a new technique to assign a sparse prior in this paper and propose effi-
cient MCMC scheme using Hamiltonian Monte Carlo sampling. Posterior consistency
is demonstrated.
In our results on the real dataset, we find that allele 4 of APOE gene is always among
the top three significant covariates for almost all the cases in Table 4. The fact that
allele 4 of the APOE gene is significant was established in Hostage et al. (2014). They
used a linear model, similar to the model in (7.3). Allele 4 is not found to be significant
for the linear case in Table 5 as well as for several other regions in the linear case. But it
is always ranked among top three most significant covariates for the non-linear model.
For this dataset, linear model is not suitable. We identify 11 significant genes. There are
some previous studies that also noted the significant genes from our analysis as possible
candidates for the AD and/or cerebral atrophy. The genes along with associated future
study citing that gene in connection with AD and/or cerebral atrophy are mentioned
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Table 5: Estimates of covariates for Total Brain for slope from linear model.
Value Std.Error DF t-value p-value
time 0.013 0.001 2155 13.208 0.000
APOEallele4:time 0.000 0.001 2155 0.047 0.962
APOEallele2:time −0.001 0.002 2155 −0.249 0.804
Gender:time 0.003 0.001 2155 3.077 0.002
MCI:time 0.006 0.001 2155 4.811 0.000
AD:time 0.014 0.002 2155 6.969 0.000
Age:time −0.002 0.000 2155 −4.663 0.000
APOEallele4:MCI:time 0.004 0.002 2155 2.689 0.007
APOEallele4:AD:time 0.004 0.002 2155 2.105 0.035
APOEallele2:MCI:time 0.001 0.003 2155 0.292 0.770
APOEallele2:AD:time −0.003 0.006 2155 −0.530 0.596
here SLC6A1 (cerebellum) (Carvill et al., 2015), KCNIP4 (Himes et al., 2013), ADGRL3
(Orsini et al., 2016), SORBS2 (Zhang et al., 2016; Lee et al., 2014; Niceta et al., 2015),
LPAR3 (Yung et al., 2015), SHROOM3 (Dickson et al., 2015; Freudenberg-Hua et al.,
2016), SORCS3 (Breiderhoff et al., 2013; Lane et al., 2012), NPY2R (Lin et al., 2010;
Schriemer et al., 2016), CWF19L2 (Lin et al., 2013), PALLD (Nho et al., 2015) and
KCNMA1 (Burns et al., 2011; Tabarki et al., 2016). In particular, SLC6A1 has been
found to affect cerebellum (Carvill et al., 2015); ADGRL3 affects hippocampus, the
prefrontal cortex, and the striatum (Orsini et al., 2016); LPAR3 affects central and
peripheral nervous tissues (Yung et al., 2015); SORCS3 and PALLD affect hippocampus
(Breiderhoff et al., 2013; Nho et al., 2015); KCNMA1 affects olfactory bulb, cortex, basal
ganglia, hippocampus, thalamus, cerebellum, vestibular nuclei, and spinal cord (Tabarki
et al., 2016).
We have kept the low dimensional covariates fixed with time. One interesting future
direction would be to modify the model to incorporate time varying covariates as well.
For example, disease status of some of the participants changed during the span of this
study. Although they were very small in number and we ignored them from this study,
it would be useful to consider them as well using a more elaborate model. Also, we
have not included MMSE scores into our analysis. This would be interesting to study
the effect of that covariate as well. Our proposed model limits us to choose a unique
set of genes across all the regions. We can modify to select separate sets of genes for
different parts of the brain with additional computational burden. This would give us
more insights about inter dependence between genes and different parts of the brain.
An package to fit high dimensional single index model as well as also to fit linear
regression with Dirichlet-Laplace and horseshoe priors using HMC is https://github.
com/royarkaprava/High-Dimensional-Single-index-model.
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